AVTR Stock Recent News
AVTR LATEST HEADLINES
Avantor Inc. AVTR stock is trading lower on Friday after the company reported worse-than-expected second-quarter 2025 adjusted EPS.
Avantor, Inc. (NYSE:AVTR ) Q2 2025 Earnings Conference Call August 1, 2025 8:00 AM ET Company Participants Allison K. Hosak - Senior VP of Global Communications & Brand Michael Stubblefield - President, CEO & Director R.
Although the revenue and EPS for Avantor (AVTR) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Avantor, Inc. (AVTR) came out with quarterly earnings of $0.24 per share, missing the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.25 per share a year ago.
Net sales of $1.68 billion, decrease of 1%; organic revenue was flat Net income of $65 million; Adjusted EBITDA of $280 million Diluted GAAP EPS of $0.09; adjusted EPS of $0.24 Operating cash flow of $154 million; free cash flow of $125 million RADNOR, Pa. , Aug. 1, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for its second fiscal quarter ended June 30, 2025.
Seasoned Executive with Proven Track Record of Value Creation in Life Sciences RADNOR, Pa. , July 21, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced that it has named Emmanuel Ligner, President and Chief Executive Officer, effective August 18, 2025.
RADNOR, Pa. , June 27, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its second quarter 2025 financial results before the market opens on Friday, August 1, and will hold a conference call on the same day at 8:00 a.m.
Avantor is trading at its lowest valuation since 2019, attracting significant management buying of the stock, with clear chart accumulation trends since April. AVTR has been aggressively repaying debt, selling assets and restructuring operations, aiming for $400-500 million in annual savings by late 2026, especially if sales rebound. Risks include potential trade tariffs, U.S. healthcare research spending cuts, and recession, but insider votes of confidence (share buying) suggest a bullish outlook for new investment.
RADNOR, Pa. , May 16, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that Brent Jones, Executive Vice President and Chief Financial Officer, will be participating in a fireside chat at the RBC Capital Markets Global Healthcare Conference in New York on Tuesday, May 20, 2025 at approximately 8:00 a.m.
RADNOR, Pa. , May 2, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that Michael Stubblefield, President and CEO, will be participating in a fireside chat at the Bank of America Securities 2025 Health Care Conference in Las Vegas on Tuesday, May 13, 2025 at approximately 10:00 a.m.